The predecessor of Jilin Aodong Pharmaceutical Group Co., Ltd. was the state-owned Yanbian Dunhua Luchang established in 1957. Aodong Pharmaceutical Factory was established in 1981. In March 1993, it was reorganized into Jilin Aodong Pharmaceutical Group Co., Ltd. with the approval of the Provincial Sports Reform Commission. The company was listed on the Shenzhen Stock Exchange on October 28, 1996. The company currently holds 7 professional pharmaceutical subsidiaries engaged in modern Chinese medicine, biochemical drugs and phytochemical drugs, 1 pharmaceutical sales subsidiary, 2 pharmaceutical supporting subsidiaries and shares in GF Securities and Tadong Mining, and has planting and breeding bases. Established an industrial chain operation model of "company + standardized base + franchised farmers" and gradually developed into a holding group integrating "resource sharing, scientific management, and sustainable development" that integrates the pharmaceutical industry, securities industry, mining industry and highway construction industry. company.

The company's registered address is No. 2158 Aodong Street, Dunhua City, Jilin Province. The company's total share capital is 573.35797 million shares, and the legal representative is Li Xiulin.

As of the end of 2009, the company's total assets were RMB 7162.21 million, its net assets were RMB 6560.37 million, and its debt-to-asset ratio was 8.40%. In 2009, the sales revenue was RMB 1025.52 million, the total profit was RMB 1413.13 million, and the net profit was RMB 1366.49 million.

In 1998, the company was recognized as a national technology center by the State Economic and Trade Commission and became the main technical support for enterprise technological progress and technological innovation. On December 11, 2001, the Ministry of Personnel approved the establishment of a postdoctoral workstation. During the 11th Five-Year Plan period, Jilin Aodong National Technology Center was built into a new technology research and development center, an industry-university-research cooperation and exchange center, and a technical decision-making consulting center; in 2002, the company Approved by the Ministry of Agriculture and nine other ministries and commissions as a national key leading enterprise in agricultural industrialization; in September 2003, it was rated as an "Excellent High-tech Enterprise in the Torch Program" by the Ministry of Science and Technology; in January 2002, it was rated as a demonstration enterprise for the modern science and technology industry base of traditional Chinese medicine ;In April 2007, he won the National May 1st Labor Certificate and was once again rated as a leading enterprise in agricultural industrialization by the Ministry of Agriculture and nine other ministries and commissions; in January 2008, he was rated as a demonstration unit for enterprise informationization in Jilin Province, and won the Jilin Province A for many years Taxpayer enterprise, AAA bank credit rating, contract-abiding and credit-oriented unit, etc.; in December 2009, he won the 16th National First-Class Enterprise Management Modernization Innovation Achievements.

After decades of development, the company has formed a unique brand advantage. The "Aodong and Tu" trademark was recognized as a well-known protection by the State Administration for Industry and Commerce in 1999, and has become the "China's 500 Most Valuable Brand" for six consecutive years. The company's leading products "Anshen Bu Brain Liquid", "Xuefu Zhuyu Oral Liquid", "Li Naoxin Capsules", and "Xin Nao Shutong Capsules" have maintained the titles of provincial, ministry and famous Chinese traditional Chinese medicine products for many years. "Calf spleen extract injection", "Riben nucleic acid II for injection", "Lufei granules", "Shaofu Zhuyu granules", "Yangxueyin oral liquid", "Yuxindou Capsule", "Children Chai Gui Products such as oral liquid have also been well received by the market for their stable quality and efficacy. The sales volume has increased year by year, laying a solid foundation for the company's sustainable development.

The company will continue to thoroughly implement the policy of "strengthening fine production management, deepening marketing system reform, adjusting product research and development direction, promoting information network construction, improving business target assessment, and enhancing the comprehensive strength of the enterprise", create greater value for shareholders, and take into account consumption. The interests of those who are involved in the social and economic development and other related parties will contribute to the development of the society and economy.